Filing Details
SPRUCE BIOSCIENCES, INC. (NASDAQ:SPRB) filed a Form 8-K with the Securities and Exchange Commission on August 12, 2026, disclosing a material event.
8k filedNASDAQ:SPRB
SPRUCE BIOSCIENCES, INC. (SPRB) Reports Material Event to SEC
SPRUCE BIOSCIENCES, INC. (NASDAQ:SPRB) filed a Form 8-K with the Securities and Exchange Commission on August 12, 2026, disclosing a material event.
At publication ·
What changed
SPRUCE BIOSCIENCES, INC. (NASDAQ:SPRB) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Spruce Biosciences filed a Form 8-K with the SEC on August 12, 2026, disclosing a material event that shareholders should be aware of, though the specific nature of the event is not detailed in this filing notice.
- The company's stock trades at $47.07 with a market capitalization of $51.6 million as a healthcare company on the NASDAQ.
- Form 8-K filings report material events such as leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance that occur between regular quarterly or annual reports.
Market Context
SPRUCE BIOSCIENCES, INC.'s stock currently trades at $47.07 with a market capitalization of $51.6M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for SPRUCE BIOSCIENCES, INC.'s stock.
All SEC filings for SPRUCE BIOSCIENCES, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View SPRB Stock Page
Frequently Asked Questions
Where can I read SPRB's SEC filings?
Browse all filings on our SPRB SEC filings page.
What types of SEC filings does SPRUCE BIOSCIENCES, INC. file?
Public companies like SPRUCE BIOSCIENCES, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.